CORE--GENE ENVIRONMENT INTERACTION & DISEASE PREVENTION

核心--基因环境相互作用

基本信息

  • 批准号:
    7393265
  • 负责人:
  • 金额:
    $ 7.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2008-03-31
  • 项目状态:
    已结题

项目摘要

Description (provided by applicant): The Research Core in Gene-Environment Interaction and Disease Prevention draws upon the multi-disciplinary expertise present in the Departments of Environmental Health Sciences and Epidemiology, to develop, validate and use molecular biomarkers to render a more basic understanding of between the relationship exposure, dose, and susceptibility, and to apply these tools to collaborative epidemiologic and intervention studies. The Research Core has the following goals, in support of this objective: 1) To provide a focus for the development and validation of molecular biomarkers. The Research Core brings together laboratory scientists and epidemiologists to apply methods of analytical chemistry, molecular biology, biochemistry, immunology, toxicology, epidemiology and biostatistics to roles the assessment of the individual risk of disease. 2) To facilitate collaborations between basic scientists and epidemiologists that optimize application of molecular biomarkers to population-based studies that address the impact of gene-environment interactions in the etiology of disease. In turn, findings from these human studies can provide insights and opportunities for Center investigators to develop and evaluate strategies for disease prevention. 3) To develop advanced methodologies for assessing past and current exposures to toxic agents in populations. In particular, this Research Core is active in the application of advanced statistical methods to human and experimental biomarker studies. 4) To develop ties to the communities of the city and state in collaboration with other Center Cores for the purposes of studying environmental risk factors contributing to acute and chronic diseases in the region. 5) To continue the development of training programs in biomarker research that will provide new opportunities and career paths for the diverse pre-and postdoctoral students at our institution.
描述(由申请人提供):基因-环境相互作用和疾病预防研究核心利用环境健康科学和流行病学部门的多学科专业知识,开发,验证和使用分子生物标志物,以提供对暴露,剂量和易感性之间关系的更基本理解,并将这些工具应用于协作流行病学和干预研究。为了支持这一目标,研究核心有以下目标:1)为分子生物标志物的开发和验证提供重点。研究核心将实验室科学家和流行病学家聚集在一起,应用分析化学、分子生物学、生物化学、免疫学、毒理学、流行病学和生物统计学的方法来评估个体疾病风险。2)促进基础科学家和流行病学家之间的合作,优化分子生物标志物在基于人群的研究中的应用,以解决基因-环境相互作用在疾病病因学中的影响。反过来,这些人类研究的结果可以为中心研究人员提供见解和机会,以制定和评估疾病预防策略。3)开发先进的方法来评估过去和现在人群中接触有毒物质的情况。特别是,这个研究核心活跃于先进的统计方法应用于人类和实验生物标志物研究。4)与其他中心核心合作,发展与城市和州社区的联系,以研究导致该地区急性和慢性疾病的环境风险因素。5)继续发展生物标志物研究方面的培训项目,为我校各类博士生提供新的机会和职业发展道路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL T STRICKLAND其他文献

PAUL T STRICKLAND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL T STRICKLAND', 18)}}的其他基金

MOLECULAR BIOMARKERS OF EXPOSURE AND SUSCEPTIBILITY IN HUMAN COLON CANCER
人类结肠癌暴露和易感性的分子生物标志物
  • 批准号:
    6467578
  • 财政年份:
    2001
  • 资助金额:
    $ 7.27万
  • 项目类别:
MOLECULAR BIOMARKERS OF EXPOSURE AND SUSCEPTIBILITY IN HUMAN COLON CANCER
人类结肠癌暴露和易感性的分子生物标志物
  • 批准号:
    6320846
  • 财政年份:
    2000
  • 资助金额:
    $ 7.27万
  • 项目类别:
MOLECULAR BIOMARKERS OF EXPOSURE AND SUSCEPTIBILITY IN HUMAN COLON CANCER
人类结肠癌暴露和易感性的分子生物标志物
  • 批准号:
    6106355
  • 财政年份:
    1999
  • 资助金额:
    $ 7.27万
  • 项目类别:
MOLECULAR BIOMARKERS OF EXPOSURE AND SUSCEPTIBILITY IN HUMAN COLON CANCER
人类结肠癌暴露和易感性的分子生物标志物
  • 批准号:
    6271226
  • 财政年份:
    1998
  • 资助金额:
    $ 7.27万
  • 项目类别:
MOLECULAR BIOMARKERS OF EXPOSURE AND SUSCEPTIBILITY IN HUMAN COLON CANCER
人类结肠癌暴露和易感性的分子生物标志物
  • 批准号:
    6239645
  • 财政年份:
    1997
  • 资助金额:
    $ 7.27万
  • 项目类别:
DNA REPAIR AND SUSCEPTIBILITY TO SKIN CANCER
DNA 修复和皮肤癌易感性
  • 批准号:
    2097605
  • 财政年份:
    1992
  • 资助金额:
    $ 7.27万
  • 项目类别:
ROLE OF DNA REPAIR IN SUSCEPTIBILITY TO SKIN CANCER
DNA 修复在皮肤癌易感性中的作用
  • 批准号:
    3201225
  • 财政年份:
    1992
  • 资助金额:
    $ 7.27万
  • 项目类别:
ROLE OF DNA REPAIR IN SUSCEPTIBILITY TO SKIN CANCER
DNA 修复在皮肤癌易感性中的作用
  • 批准号:
    3201224
  • 财政年份:
    1992
  • 资助金额:
    $ 7.27万
  • 项目类别:
SUSCEPTIBILITY DETERMINANTS FOR PHOTOCARCINOGENESIS
光致癌的易感性决定因素
  • 批准号:
    3456886
  • 财政年份:
    1988
  • 资助金额:
    $ 7.27万
  • 项目类别:
SUSCEPTIBILITY DETERMINANTS FOR PHOTOCARCINOGENESIS
光致癌的易感性决定因素
  • 批准号:
    3456883
  • 财政年份:
    1988
  • 资助金额:
    $ 7.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了